Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
The cancer drug Vecade (bortezomib) combined with glucocorticoids could be a treatment option for people with drug-resistant lupus nephritis (LN), suggests a study published in the scientific journal Lupus.
Patients with one autoimmune disease should be closely monitored because they may have a higher risk of developing another autoimmune disease according to a study published in the journal Autoimmune ... Read more
The flu vaccine is effective and associated with a lower risk of hospitalization, pneumonia, admission to the intensive care unit, in-hospital dialysis, and death in people with systemic lupus erythematosus ... Read more
Maintaining optimal levels of vitamin D in the blood could be protective against the risk of cardiovascular disease often seen in systemic lupus erythematosus (SLE) patients, according to a large ... Read more
Autoantibodies that naturally occur in the body of a population of patients with an ultra-rare type of autoimmune disorder called autoimmune polyendocrine syndrome type 1 (APS1 or APECED), could help ... Read more